MUSK and myasthenia gravis: Patient demographics and clinical characteristics in our study were largely similar to those reported by the Japanese myasthenia gravis registry (JAMG-R) (12), in which mean patient age was 60 years, 60% of patients were female, 44% were MGFA Class II, 82% were anti-AChR, and 3% were anti-MuSK positive.